CASP3 and chronic myelogenous leukemia, BCR-ABL1 positive: ATO-induced ROS and intracellular redox imbalance stimulate the p38 MAPK pathway and induce apoptosis via the caspase-3 pathway, establishing the role of ATO in anticancer treatments for APL and chronic myelogenous leukemia (CML) [95].